The Advanced Approval Pathway for Longevity Medicines (AAPLM) seeks to accelerate the development of groundbreaking therapies targeting aging, improving health, reducing healthcare costs, and boosting economic productivity.
AAPLM’s provisions include a faster drug approval track, priority review vouchers to incentivize innovation, and patent term extensions to encourage broad therapeutic applications. By aligning economic incentives with transformative health outcomes, AAPLM aims to unlock the potential of longevity science, benefiting individuals and society while imposing no additional taxpayer costs.